Benzinga's Top #PreMarket Gainers

Loading...
Loading...
Collegium Pharmaceutical IncCOLL
shares rose 41.26 percent to $19.00 in pre-market trading after the company reported that the FDA Advisory Committees have unanimous recommended the approval of Xtampza ER.
Aquinox Pharmaceuticals Inc AQXP
shares jumped 23.17 percent to $21.26 in pre-market trading after gaining 4.86 percent on Friday.
Geron Corporation GERN
shares rose 4.82 percent to $3.70 in pre-market trading after surging 4.44 percent on Friday.
Vertex Pharmaceuticals Incorporated VRTX
gained 1.52 percent to $136.10 in pre-market trading. Analysts at Barclays upgraded Vertex Pharmaceuticals from Equal-weight to Overweight and raised the price target from $120.00 to $150.00.
Apple Inc. AAPL
shares climbed 1.22 percent to $115.60 in pre-market trading after rising 1.46 percent on Friday.
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...